1993
DOI: 10.1002/j.1552-4604.1993.tb03896.x
|View full text |Cite
|
Sign up to set email alerts
|

Antihypertensive Therapy in the Geriatric Patient: II. A Review of the Alpha1‐Adrenergic Blocking Agents

Abstract: The prevalence of hypertension increases with age. Multiple physiologic factors are involved in the development of hypertension in the elderly. Alpha1-adrenergic blocking agents lower blood pressure through a reduction in total peripheral resistance. Prazosin, terazosin, and doxazosin have been shown to be equally effective in reducing blood pressure in older persons. The bioavailability, terminal elimination half-life, and volume of distribution of prazosin is increased in the elderly. Hybrid drugs, such as k… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

1995
1995
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 49 publications
0
5
0
Order By: Relevance
“…The major reason that Japanese physicians are reluctant to use α‐blockers in elderly patients is their side‐effect profile. In contrast, some studies have shown that α‐blockers appear to be effective as first‐line agents in the elderly [ 19 –21]. In addition, they have several advantages over other antihypertensive agents.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The major reason that Japanese physicians are reluctant to use α‐blockers in elderly patients is their side‐effect profile. In contrast, some studies have shown that α‐blockers appear to be effective as first‐line agents in the elderly [ 19 –21]. In addition, they have several advantages over other antihypertensive agents.…”
Section: Discussionmentioning
confidence: 99%
“…The incidence of vertigo with doxazosin treatment recorded the exception of postural hypotension, a-blockers have in a post-marketing survey conducted in Japan[19].…”
mentioning
confidence: 99%
“…Prazosin is an α1-adrenergic receptor antagonist (Studer and Piepho, 1993), an NRH:quinone reductase antagonist (Pegan et al, 2011) and a Mel1c melatonin receptor antagonist (Chen et al, 2016). In this study, prazosin (0.1 µmol l −1 to 1 mmol l −1 ) was used to assess the activity of the Mel1c melatonin receptor in developing chick embryos.…”
Section: Melatonin Receptor Pharmacology In Chick Embryosmentioning
confidence: 99%
“…Bioavailability and distribution volume are increased. [51] The sensitivity to the product is conserved in elderly people. (52) As with other <XI-receptor blockers, orthostatic hypotension has been described, mainly due to impaired baroreflex activity.…”
Section: 5 Other Antihypertensive Drugsmentioning
confidence: 99%